References
- Kamr AG, Abdel-Latif NA, Abdalla, MM. Synthesis and antiandrogenic activity of some new 3-substituted androstano[17,16-c]-5′-aryl-pyrazoline and their derivatives. Bioorg Med Chem 2007;15:373–384.
- Ruhoglu O, Ozdemir Z, Calis U, Gümüsel B, Bilgin AA. Synthesis of and pharmacological studies on the antidepressant and anticonvulsant activities of some 1,3,5-trisubstituted pyrazolines. Arzneimittelforschung 2005;55:431–436.
- Shafiee A, Bagheri M, Shekarchi M, Abdollahi M. The antinociceptive activities of 1-(4-aryl-2-thiazolyl)-3,5-disubstituted-2 pyrazolines in mouse writhing test. j Pharm Pharm Sci 2003;6:360–362.
- Sivakumar PM, Seenivasan SP, Kumar V, Doble M. Novel 1,3,5-triphenyl-2-pyrazolines as anti-infective agents. Bioorg Med Chem Lett 2010;20:3169–3172.
- Suliphal Devara MB, Bennikallu Hire Mathada M. Synthesis and antimicrobial activity of some 5-substituted-3-phenyl-N beta-(substituted-2-oxo-2H-pyrano[2,3-b]quinoline-3-carbonyl)-1H-indole-2-carboxyhydrazide. Chem Pharm Bull (Tokyo) 2009;57:557–560.
- Berghot MA, Moawad EB. Convergent synthesis and antibacterial activity of pyrazole and pyrazoline derivatives of diazepam. Eur j Pharm Sci 2003;20:173–179.
- Palaska E, Aytemir M, Uzbay IT, Erol D. Synthesis and antidepressant activities of some 3,5-diphenyl-2-pyrazolines. Eur j Med Chem 2001;36:539–543.
- Turan-Zitouni G, Ozdemir A, Güven K. Synthesis of some 1-[(N, N-disubstituted thiocar bamoylthio)acetyl]-3-(2-thienyl)-5-aryl-2-pyrazoline derivatives and investigation of their antibacterial and antifungal activities. Arch Pharm (Weinheim) 2005;338:96–104.
- Jeong TS, Kim KS, An S, An SJ, Cho KH, Lee S et al. Novel 3,5-diaryl pyrazolines as human acyl-CoA:cholesterol acyltransferase inhibitors. Bioorg Med Chem Lett 2004;14:2715–2717.
- Foks H, Pancechowska-Ksepko D, Janowiec M, Zwolska Z, Augustynowicz-Kopec E. Synthesis and tuberculostatic activity of some (4-phenylpiperazin-1-ylmethyl)-1,3,4-oxadiazole and (4-phenylpiperazin-1-ylmethyl)-1,2,4-triazole derivatives. Acta Pol Pharm 2004;61:473–476.
- Bethge K, Pertz HH, Rehse K. New oxadiazole derivatives showing partly antiplatelet, antithrombotic and serotonin antagonistic properties. Arch Pharm (Weinheim) 2005;338:78–86.
- Ali MA, Shaharyar M, Siddiqui AA. Synthesis, structural activity relationship and anti-tubercular activity of novel pyrazoline derivatives. Eur j Med Chem 2007;42:268–275.
- Ali MA, Shaharyar M. Oxadiazole mannich bases: synthesis and antimycobacterial activity. Bioorg Med Chem Lett 2007;17:3314–3316.
- Shaharyar M, Ali MA, Bakht MA, Murugan V. Synthesis and antimycobacterial activity of 4-[5-(substituted phenyl)-4, 5-dihydro-3-isoxazolyl]-2-methylphenols. j Enzyme Inhib Med Chem 2008;23:432–436.
- Ragavan RV, Vijayakumar V, Kumari NS. Synthesis and antimicrobial activities of novel 1,5-diaryl pyrazoles. Eur j Med Chem 2010;45:1173–1180.
- Heifets LB, Flory MA, Lindholm-Levy PJ. Does pyrazinoic acid as an active moiety of pyrazinamide have specific activity against Mycobacterium tuberculosis? Antimicrob Agents Chemother 1989;33:1252–1254.
- Gundersen LL, Nissen-Meyer J, Spilsberg B. Synthesis and antimycobacterial activity of 6-arylpurines: the requirements for the N-9 substituent in active antimycobacterial purines. J Med Chem 2002;45:1383–1386.